A mutation in gene CNGA3 is associated with day blindness in sheep  by Reicher, Shay et al.
Genomics 95 (2010) 101–104
Contents lists available at ScienceDirect
Genomics
j ourna l homepage: www.e lsev ie r.com/ locate /ygenoA mutation in gene CNGA3 is associated with day blindness in sheep☆
Shay Reicher a,b, Eyal Seroussi a, Elisha Gootwine a,⁎
a Institute of Animal Science, Agricultural Research Organization, The Volcani Center, P.O. Box 6, Bet Dagan 50250, Israel
b The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Israel☆ Sequence data from this article have been deposit
Data Library under GenBank Accession nos. FN37757
(CNGA3); FM946177 (CNGB3) and FM946178 (GNAT2).
⁎ Corresponding author. Fax: +972 3 9603678.
E-mail address: gootwine@agri.gov.il (E. Gootwine).
0888-7543/$ – see front matter © 2009 Elsevier Inc. A
doi:10.1016/j.ygeno.2009.10.003a b s t r a c ta r t i c l e i n f oArticle history:
Received 26 June 2009
Accepted 21 October 2009







GNAT2Lambs with congenital day blindness show diminished cone function, which is characteristic of
achromatopsia, a congenital disorder described in humans and dogs. To identify gene(s) associated with
sheep day blindness, we investigated mutations in the CNGA3, CNGB3, and GNAT2 genes which have been
associated with achromatopsia. Sequencing the coding regions of those genes from four affected and eight
non-affected lambs showed that all affected lambs were homozygous for a mutation in the CNGA3 gene that
changes amino acid R236 to a stop codon. By PCR-RFLP-based testing, homozygosity for the stop codon
mutation was detected in another 19 affected lambs. Non-affected individuals (n=386) were non-carriers
or heterozygous for the mutation. While a selection program has been launched to eradicate the day
blindness mutation from Improved Awassi ﬂocks, a breeding nucleus of day-blind sheep has been
established to serve as animal models for studying human achromatopsia.
© 2009 Elsevier Inc. All rights reserved.Introduction
A novel congenital day blindness in sheep that is inherited in an
autosomal recessive mode has been recently reported in the
Improved Awassi breed [1]. Sporadic birth of visually impaired
lambs was ﬁrst recorded in 2003 at the Ein Harod ﬂock, Israel. With
time, the proportion of the affected lambs born in the ﬂock
gradually increased, reaching by 2008 the value of 3.5% (unpub-
lished results). This newly discovered illness is associated with
diminished function of cones but not of rods, resembling achroma-
topsia described in humans in its incomplete mode [2,3]. This form
of blindness differs in its etiology from other known cases of
inherited sheep blindness such as ceroid lipofuscinosis [4] or
blindness related to microphthalmia [5].
Complete or typical achromatopsia is an autosomal recessive
disease, in which patients manifest reduced visual acuity, lack of
color vision, photophobia and nystagmus essentially from birth,
while maintaining a normal- or near-normal-looking fundus. Cone
electroretinogram (ERG) responses and color vision are absent [6].
The presentation of incomplete or atypical achromatopsia is
similar, except that some color vision and improved acuity are
present [7].
Most cases of human achromatopsia have been associated
with mutations in three genes that play a major role in the coneed in the DDBJ/EMBLGenBank
4, FN377575 and FM946176.
ll rights reserved.phototransduction cascade. Two of these genes code for the
cone photoreceptor cyclic nucleotide-gated (CNG) channel sub-
units α and β—CNGA3 and CNGB3, respectively [8,9]. Cone CNG
channels are tetramers of two α and two β subunits and are
non-selective cation channels located in the membrane of cone
photoreceptors. CNG channels are open in the dark. Light
stimulation leads to CNG channel closure and consequently to
the absence of cation inﬂux and membrane hyperpolarization,
which diminishes glutamate release at the photoreceptor synapse
[10].
CNGB3 has been estimated to account for 40–60% of achro-
matopsia in humans [11,12]. About 28 pathogenic mutations have
been found within the human CNGB3 gene, most of them
nonsense or frameshift mutations. Mutations in or deletion of
the canine CNGB3 gene have been also associated with day
blindness in German Shorthaired Pointer and Alaskan Malamute
dogs [13,14]. CNGA3 mutations account for about 20–30% of the
cases of human achromatopsia. About 69 mutations have been
detected within the CNGA3 gene in human patients with
achromatopsia, most of them of the missense type [2,12,15–20].
A minor fraction, about 2%, of achromatopsia cases in humans
have been associated with mutations in a third gene, GNAT2,
encoding the α-subunit of the cone photoreceptor transducin G-
protein gene [21–23].
Applying a “candidate gene approach,” we searched for the
mutation that underlies day blindness in sheep by comparing the
sequences of exons of ovine CNGA3, CNGB3 and GNAT2 genes between
affected and non-affected individuals. Our results show that a stop
codon mutation in the ovine CNGA3 gene is associated with day
blindness in Improved Awassi sheep.
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Cloning of major ovine cone phototransduction genes
RNA extracted from retinas of non-affected lambs belonging to the
Improved Awassi (n=4) and local Awassi (n=2) breeds, as well as to
an American Suffolk cross (n=2) was reverse-transcribed using PCR
primers designed based on the orthologous bovine genes (Supple-
mentary Table 1). We were able to PCR amplify the complete CNGA3
and CNGB3 coding regions and partial GNAT2 coding region of the
putative candidate genes.
CNGA3 sequencing results: sequencingof the PCR-ampliﬁedproducts
showed that the entire ovine CNGA3 coding region comprises 2103
nucleotides (GenBank accession FN377574 and FN377575), coding for
700 amino acids. The polypeptides encoded by these sequences showed
95% identity and97% similarity to the orthologous bovineCNGA3protein
(GenBank accession no. NP_776704, Supplementary Fig. 1).
Alignment of ovine CNGA3 cDNA sequences of the eight non-
affected individuals revealed a total of 18 synonymous and nine non-
synonymous polymorphic sites (Table 1). The two Suffolk crossbred
lambs were homozygous for the same CNGA3 haplotype. At least
seven additional haplotypes were evident in the other six normal
Improved Awassi and local Awassi individuals.
Two of the nine non-synonymous polymorphic sites, namely L217F
and K265R, were located in conserved transmembrane domains S2
and S3, respectively (Supplementary Fig. 1). Other non-synonymous
polymorphic sites were in the less conserved sequence regions.
CNGB3 sequencing results: sequence analysis showed that the
entire coding region of the ovine CNGB3 comprises 2304 nucleotides
(GenBank accession no. FM946177), coding for 767 amino acids, with
92% identity and 93% similarity to the orthologous bovine protein
(GenBank accession no. XP_597439, Supplementary Fig. 2).
Sequence alignment of eight non-affected individuals revealed
seven synonymous and 10 non-synonymous (Supplementary Table 2)
polymorphic sites within the ovine CNGB3 coding region. One of the
Improved Awassi lambs was found to be homozygous for the same
CNGB3 haplotype and at least six additional haplotypes were evident
in the other seven non-affected individuals.
Three of the 10 non-synonymous polymorphic sites found in non-
affected individuals, namely E188K, R336Q and T564M, were located
in conserved regions of the CNGB3 gene (Supplementary Fig. 2). Other
non-synonymous polymorphic sites were in the less conserved
sequence regions.Table 1
Non-synonymous polymorphism detected in the ovine CNGA3 cDNA in normal and day-bli
Suffolk cross 1 sequence marked in gray, is used as a reference sequence. Only deviations f
a GenBank accession no. FN377574.
b GenBank accession no. FN377575.
c GenBank accession no. FM946176.GNAT2 sequencing results: partial sequencing (exons 4-8) of ovine
GNAT2 cDNA (GenBank accession no. FM946178) showed a single
synonymous polymorphism (T439C). The polypeptide encoded by
this sequence was identical to the orthologous bovine, equine and
canine proteins (GenBank accession nos. NP_776751, XP_001495066
and XP_547240, respectively).
Sequencing candidate genes in day-blind sheep
CNGA3
All four day-blind lambs were homozygous for a CNGA3 haplotype
that was not observed in non-affected individuals, and which differed
from the Suffolk-cross haplotype by four non-synonymous mutations
(GenBank accession no. FM946176.) (Table 1). One of the mutations
(C706T) truncated the encoded polypeptide at position 236 (Fig. 1) at
the end of transmembrane domain S2.
Such early truncation is likely to render a non-functional cone CNG
channel, leading to day blindness. Interestingly, a similar C→T
substitution leading to the appearance of a stop codon was detected
in the human CNGA3 gene at residue 221 [17], which is orthologous to
ovine residue 236. In contrast to the day-blind sheep in this study,
which manifested impaired but not abolished cone function [1], the
patient that carried the mutation in a homozygous situation had
complete achromatopsia with photophobia, nystagmus, decreased
visual acuity (OD-OS 6/60-6/36), and absence of photopic (cone) ERG.
To further investigate the association between the C706Tmutation
in CNGA3 and day blindness in sheep, we examined this position by
PCR-RFLP in 19 affected and 386 non-affected Improved Awassi rams
and ewes from ﬂocks where day blindness has been segregating
(Fig. 2). All 19 affected lambswere homozygous T/T, while 289 and 97
of the healthy lambs were either homozygous C/C for the wild-type
allele, or heterozygous C/T, respectively.
CNGB3
While all four affected lambs were homozygous for the same
CNGA3 haplotype, a different result was obtained upon sequencing of
their CNGB3 gene—one affected lamb was homozygous for a haplo-
type found in normal lambs, and the three others were heterozygous
for ovine CNGB3 haplotypes (Supplementary Table 2). These results
make the ovine CNGB3 locus an unlikely candidate for the Improved
Awassi day blindness, as homozygosity is expected near the locus
carrying the deleterious recessive alleles in the genomes of all affected
individuals.nd sheep.
rom the reference sequence are indicated.
Fig. 1. Mutation analysis of the ovine CNGA3 gene. Sequence analysis of cDNA from a
non-carrier, heterozygous carrier, and homozygous day-blind mutant. An arrow
denotes the position of the mutation.
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All four affected lambs were heterozygous for the T439C
polymorphism, excluding GNAT2 homozygocity in the affected
lambs. Although the gene was partially sequenced, this observation,
coupled with that of identical proteins being encoded by GNAT2
sequences obtained from both unaffected and affected lambs, support
the notion that ovine GNAT2 is an unlikely candidate locus for the
Improved Awassi day blindness.
Use of the “candidate gene approach” in the present study
effectively identiﬁed CNGA3 as the gene responsible for day blindness
in Improved Awassi sheep. This approach was also effective in
associating human achromatopsia with a mutation in the GNAT2 gene
[21]. However, a similar approach failed to identify candidate genes
associated with microphthalmia in sheep [5], or candidate genes
associated with day blindness in the Standard Wire-Haired Dachs-
hund dog [24]. In the latter case, a whole-genome association study of
discordant sib-pairs, genotyped with the canine single nucleotide
polymorphism (SNP) array, was applied to identify the gene that
causes the illness [25].
The origin of the CNGA3mutation described in the present study is
the Ein Harod Improved Awassi ﬂock [1]. This has been a closed ﬂock,
with no entry of foreign genetic material, for several decades. The
CNGA3 mutation event occurred before 2003, the year in which the
birth of blind lambs was ﬁrst recorded. From 2004 to 2008, the
frequency of affected lambs in that ﬂock rose from 0.5% to 3.5%
(unpublished data). Interestingly, the appearance and spread of the
ovine CNCA3 mutation in a genetically closed population resemblesFig. 2. PCR-RFLP analysis after digestion of the PCR product with Eco471 (AvaII).
Restriction enzyme: Lane 1, homozygous normal-vision lamb; A major band of 41 +
45 bp and a minor band of 21 bp are detected. Lane 2, heterozygous carrier lamb; Major
bands of 66 bp and 41 + 45 bp are detected, along with a faint minor band of 21 bp.
Lane 3, homozygous day-blind lamb; Two major bands are detected: one of 66 bp and
the other of 41 + 45 bp.that of the CNGB3mutation causing achromatopsia among the closed
population of the Pingelapese islanders of Micronesia [26].
Following the identiﬁcation of CNGA3 as the gene responsible for
day blindness, selection against carrying the day-blindness mutation
was launched in Improved Awassi ﬂocks carrying the mutation. All
males are PCR-RFLP-genotyped (Fig. 2) and rams and ram–lambs that
carry the mutation are culled (unpublished results). On the other
hand, the ﬁnding that similar stop codon mutations cause day
blindness in both humans [17] and sheep promotes use of the day-
blind sheep as a large animal model for studying and possibly treating
human achromatopsia. Indeed, gene therapy has been reported to
restore cone function in a mouse model for human achromatopsia
with a CNGA3 mutation [27]. However, it should be noted that some
differences may exist between human and ovine photoreceptor CNG
ion channel function, as patients homozygous for the stop codon
mutation at residue 221 of the human CNGA3 gene show the absence
of photopic ERG [17], while in the day-blind affected sheep, it is
impaired, but not completely absent [1].
Relatively extensive non-synonymous polymorphism was found
in the present study in the CNGA3 and the CNGB3 genes, in both
conserved and non-conserved amino acid residues (Table 1, Supple-
mentary Table 2). In contrast, no non-synonymous polymorphism
was detected in the GNAT2 gene. Whether this difference is due to the
relative tissue speciﬁcity of the GNAT2 expression pattern as
compared to expression of the CNGA3 gene, where transcripts have
been detected in various non-retinal tissues in humans [28] and other
species [29], requires further investigation.
In conclusion, our results show that a stop codon mutation in the
ovine CNGA3 gene is associated with day blindness in Improved
Awassi sheep. This ﬁnding has paved the way for molecular-based
selection against carrying themutation in commercial sheep ﬂocks. As
gene therapy is becoming a real possibility for treating retinal genetic
illnesses [30–32], sheep homozygous for the CNGA3 mutation may
serve as an animal model for studying and treating this illness in
humans.
Materials and methods
Experimental protocols were approved by the Volcani Center's
Animal Care Committee (authorization no. 16208). Four normal
Improved Awassi lambs and four impaired-vision Improved Awassi
lambs were from the Ein Harod Improved Awassi dairy ﬂock, Israel
[33]. Based on the breeding records of that ﬂock, each Improved
Awassi lambs (affected and non-affected) was sired by a different
ram. Day blind lambs were assigned based on their inability to
orientate during day time and their fail to manifest menace response
[1]. Non-affected American Suffolk crossbred lambs (n=2) were
progeny of American Suffolk rams kept at the Insemination Center at
Illania, Israel. Non-affected Local Awassi lambs (n=2) were from an
unknown Bedouin ﬂock from the south of Israel.
Retinas from the four affected and the eight non-affected lambs
were dissected from eyes collected at the abattoir a few minutes after
slaughter, immediately immersed in liquid nitrogen and kept at
−80 °C until RNA extraction. Total RNA extraction was carried out
utilizing Tri-reagent (Sigma-Aldrich, Israel), according to manufac-
turer's instructions. Total RNA (1 μg) was reverse-transcribed in a ﬁnal
volume of 20 μl containing 50 mM Tris–HCl (pH 8.3), 75 mM KCl,
5 mMMgCl2, 10 mM dithiothreitol, 0.5 mM of each deoxynucleotide,
0.5 μg oligo-dT/hexamer primers (Promega, Israel), and 1 U avian
myeloblastosis virus reverse transcriptase (Promega, Israel). The
reverse-transcription reaction temperatures were 42 °C for 1 h and
95 °C for 10 min.
To search for possible causativemutationswithin the ovine CNGA3,
CNGB3 and GNAT2 genes, fragments covering the complete (CNGA3,
CNGB3) or partial (GNAT2) coding regions of those genes were amp-
liﬁed from the cDNA samples obtained from the four affected and the
104 S. Reicher et al. / Genomics 95 (2010) 101–104eight non-affected lambs. Primers (Supplementary Table 1) were
designed using Primer3 software (http://www-genome.wi.mit.edu/
cgi-bin/primer/primer3_www.cgi), based on the orthologous bovine
genes (Supplementary Table 1). PCRs were carried out on a Thermal
Cycler 2720 (Applied Biosystems, Foster City, CA, USA) in a total
volume of 40 μl, containing cDNA template (0.5–1.0 μg/reaction),
8 pmol of each primer, 2 units of Taq DNA polymerase (Fermentas,
Burlington, Canada), 1×Taq Buffer with (NH4)2SO4 (Fermentas,
Burlington, Canada), ﬁnal concentration of 0.2 mM each dNTP, 2 mM
MgCl2 and 200 ng BSA. Ampliﬁcation parameters for each PCR are
presented in Supplementary Table 1.
PCR products were size-separated by electrophoresis on 1.2%
agarose gels stained with ethidium bromide and were extracted from
the gel using QIAquick gel extraction kit (Qiagen, Hilden, Germany)
according to manufacturer's instructions, and sequenced from both
directions with the ABI BigDye Terminator Sequencing Kit (Applied
Biosystems) on an ABI 3730. Sequences were assembled and com-
pared using the GAP4 program [34]. Protein sequences were aligned
with ClustalW software (http://clustalw.genome.jp), using default
settings and the Gonnet weight matrix. The graphical image of the
multiple alignments was created with BoxShade (http://www.ch.
embnet.org/software/BOX_form.html).
Population screening for the day-blindness mutation in CNGA3
was carried out using the PCR-RFLP method. Genomic DNA was
extracted from blood samples using standard DNA extraction
methods. PCR products of 107 bp were ampliﬁed using primers de-
signed according to the ovine gene sequence (GenBank accession
no. FN377574): sense primer 5′-GTTTCGATGAAGCTCCAGTCC-3′;
antisense primer 5′-CTCACCTGGTCCGGGCTC-3′. PCR products were
digested with Eco471 (AvaII) restriction enzyme, and size-separated
and visualized by 3.5% Metaphor agarose gel electrophoresis.
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